Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Preclinical studies support potential new indication for tamsulosin

Feb. 14, 2000

Kissei compounds display excellent beta3-adrenoceptor-stimulating effects

Feb. 11, 2000

Nastech claims formulations of sildenafil for nasal delivery

Feb. 11, 2000

Inhibitors of cGMP-PDEs under study at Bayer

Feb. 9, 2000

RenaGel receives marketing approval in the E.U.

Feb. 4, 2000

Edex/Viridal preferred, more efficacious than other ED therapies

Feb. 2, 2000

Patients prefer Invicorp over Caverject

Feb. 1, 2000

New Zeria compounds with alpha1-adrenoceptor-blocking effects

Feb. 1, 2000

OPC-41061 + furosemide: additive diuretic effect + beneficial effect on electrolytes

Jan. 31, 2000

Bayer presents new candidate treatment for ED at ESIR

Jan. 31, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...